Wire Stories
-
503Yokogawa Successfully Completes Proof of Concept for Optimization of Operations at US Wastewater Reclamation Facility Producing Potable Water
– Project receives Transformational Innovation award from the WateReuse Association – TOKYO–(BUSINESS WIRE)–#energy–Yokogawa Electric Corporation (TOKYO: 6841) announces that it has successfully...
-
573
TaiwanPlus and the Taiwan Overseas Compatriots Foundation Sign MOU for �Overlapped� Project, Fostering Dialogue Between Taiwan and the United States
TAIPEI, Taiwan–(BUSINESS WIRE)–TaiwanPlus, Taiwan�s first global English-language video streaming platform, and the Taiwan Overseas Compatriots Foundation (TOCF) signed an online MOU on...
-
511
TaiwanPlus and the Taiwan Overseas Compatriots Foundation Sign MOU for �Overlapped� Project, Fostering Dialogue Between Taiwan and the United States
TAIPEI, Taiwan–(BUSINESS WIRE)–TaiwanPlus, Taiwan�s first global English-language video streaming platform, and the Taiwan Overseas Compatriots Foundation (TOCF) signed an online MOU on...
-
493Star Equity Holdings to Present at the Maxim Group 2022 Virtual Growth Conference on March 30th
OLD GREENWICH, Conn., March 24, 2022 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (�Star Equity� or the �Company�), a...
-
521
Schools in the Middle East, Africa, and Asia Benefit from PowerSchool Solutions
Esol Education renews PowerSchool solutions for assessment, enrollment, and other key functions FOLSOM, Calif.–(BUSINESS WIRE)–PowerSchool (NYSE: PWSC), the leading provider of cloud-based...
-
605
MEI Pharma and Kyowa Kirin Provide Regulatory Update on Zandelisib Following Meeting with the FDA
� MEI to Host Zandelisib Program Update Webcast Today at 4:30 p.m. Eastern Time � SAN DIEGO & TOKYO–(BUSINESS WIRE)–MEI Pharma, Inc....
-
518
Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 Trial
Patients in phase 2 pilot trial 2-THE-TOP had median progression-free survival of 12.1 months compared with 7.9 months for matched-control patients from...
-
511
Elix, Inc. Begins Collaboration With Shionogi & Co., Ltd. on Elix Synthesize� (AI Drug Discovery Module) for Verification of Practical Retrosynthetic Analysis
TOKYO–(BUSINESS WIRE)–Elix, Inc., an AI drug discovery company with the mission of �Rethinking Drug Discovery� (CEO: Shinya Yuki/Headquarters: Tokyo; hereafter referred to...
-
499
Last Orders: Join the Final Week of the Fair Go Casino Five-year Birthday Bash
SYDNEY–(BUSINESS WIRE)–All good things must come to an end and after almost a month of partying, there is just one more week...
-
518Data443�s Antivirus Protection Manager Achieves VB100 Certification
Detected 100% of Malware in Testing � Extends Endpoint Leadership RESEARCH TRIANGLE PARK, NC, March 24, 2022 (GLOBE NEWSWIRE) — Data443 Risk...
